Press Releases

Filter by Category

Filter by Program

Filter by Publish Date

March 27, 2025

C-Path’s Predictive Safety Testing Consortium Advances a Transformative Test to Detect Drug Induced Liver Injury

Serum Glutamate Dehydrogenase Activity Enables Sensitive and Specific Diagnosis of Hepatocellular Injury in Humans TUCSON, Ariz.,

March 27, 2025

New CFO to Lead Financial Strategy and Global Compliance at C-Path TUCSON, Ariz., March 27, 2025 — Critical Path Institute® (C-

March 26, 2025

Collaboration has culminated in meaningful, lasting changes for the benefit of stakeholders...

C-Path and Boston Medical Center published results for six biomarkers that could improve the early and accurate detection...

C-Path announced the appointments of Steven W. Spector and James A. King to its Board of Directors...

February 18, 2025

Critical Path for Alpha-1 (CPA-1) consortium today announced the addition of biopharmaceutical companies, Kamada and Sanofi.

January 23, 2025

New Leadership to Drive Expansion of Collaborative Initiatives and Fundraising Strategies at C-Path.

January 14, 2025

C-Path and TRxA today officially launched its 2025 global Request for Proposals for Bridging Research...

November 19, 2024

C-Path today announced that its Translational Therapeutics Accelerator (TRxA) program, in partnership...

November 13, 2024

C-Path expands its worldwide leadership in accelerating drug development in neurology; seeks additional collaborators to broaden..